Early Access — free while we kick the tires
EdgarHawk

Pannu Geraldine

Director

Director

Latest: Director buying · March 2026

1 filing analyzed · 1 company · Latest 2026-04-01

Companies

Company Buys Sells Direction
Processa Pharmaceuticals, Inc. PCSA 1 0 Net buying

Activity

April 2026
Buy
2,072 shares
$5,253
Significance 7/10

Director Pannu purchases 2.1K shares of Processa at $2.54; 8 other insiders also bought within 14 days amid $-3.4M net loss.

Director Geraldine Pannu increased her holdings by 1786.2% from 116 to 2,188 shares via a purchase of 2,072 shares at $2.54. This transaction occurs within a cluster of 8 other insider buys in the past 14 days, a notable pattern of coordinated insider accumulation. The company carries a net loss of $-3,436,573.00 with zero revenue in the latest quarter, making this cluster buy activity particularly significant as a signal of director perception amid deteriorating financial fundamentals. The stock trades at $2.60, down 78.3% from its 52-week high of $11.97, leaving open questions about whether this cluster reflects confidence at depressed levels or commitment through operational distress.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access